O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.47B
AUM Growth
-$1.57B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
145
New
Increased
Reduced
Closed

Top Buys

1
+$95.1M
2
+$76.2M
3
+$74M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$72.1M
5
LLY icon
Eli Lilly
LLY
+$66.8M

Top Sells

1
+$205M
2
+$143M
3
+$75.8M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.3M
5
BMY icon
Bristol-Myers Squibb
BMY
+$49.2M

Sector Composition

1 Healthcare 90.2%
2 Financials 0.22%
3 Technology 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
$1.13M 0.01%
107,300
127
$1.09M 0.01%
990,745
128
$1.06M 0.01%
1,731
129
$995K 0.01%
500,000
130
$536K 0.01%
17,500
131
– –
0
132
– –
-568,850
133
– –
-155,000
134
– –
-12,000
135
– –
-487,400
136
– –
-7,511,000
137
– –
-2,988,800
2 3 4 5
6